This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Oscar Health, Inc. (OSCR) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $13.58, representing a -3.35% change from its previous close.
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
by Indrajit Bandyopadhyay
CLOV's second-quarter results are likely to reflect strong Medicare Advantage membership growth and expansion and deeper integration of Clover Assistant.
Everest Group (EG) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Everest Group (EG) delivered earnings and revenue surprises of +14.66% and +2.03%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Oscar Health, Inc. (OSCR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Oscar Health (OSCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bear of the Day: Goosehead Insurance (GSHD)
by Shaun Pruitt
One of the general rules of thumb when investing in stocks is to avoid insolvent companies, and Goosehead Insurance (GSHD) has started to check this red flag.
Why Oscar Health, Inc. (OSCR) Outpaced the Stock Market Today
by Zacks Equity Research
Oscar Health, Inc. (OSCR) concluded the recent trading session at $14.45, signifying a +1.76% move from its prior day's close.
Oscar Health, Inc. (OSCR) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $14.2, indicating a -10.52% shift from the previous trading day.
Oscar Health, Inc. (OSCR) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Oscar Health, Inc. (OSCR) closed at $15.35 in the latest trading session, marking a +2.88% move from the prior day.
Oscar Health, Inc. (OSCR) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Oscar Health, Inc. (OSCR) closed at $15.53 in the latest trading session, marking a -3.42% move from the prior day.
Why Oscar Health, Inc. (OSCR) Dipped More Than Broader Market Today
by Zacks Equity Research
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $16.55, marking a -1.55% move from the previous day.
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
Oscar Health, Inc. (OSCR) concluded the recent trading session at $16.62, signifying a -18.73% move from its prior day's close.
Oscar Health, Inc. (OSCR) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
Oscar Health, Inc. (OSCR) closed the most recent trading day at $20.45, moving 4.62% from the previous trading session.
Oscar Health, Inc. (OSCR) Stock Moves -4.15%: What You Should Know
by Zacks Equity Research
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $19.19, representing a -4.15% change from its previous close.
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $20.42, marking a -3.77% move from the previous day.
Oscar Health (OSCR) Soars 7.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Oscar Health (OSCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Oscar Health, Inc. (OSCR) Laps the Stock Market: Here's Why
by Zacks Equity Research
Oscar Health, Inc. (OSCR) reached $14.34 at the closing of the latest trading day, reflecting a +1.34% change compared to its last close.
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Oscar Health, Inc. (OSCR) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Oscar Health (OSCR) delivered earnings and revenue surprises of 10.84% and 8.75%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Assurant (AIZ) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Assurant (AIZ) delivered earnings and revenue surprises of 19.37% and 1.21%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
American International Group (AIG) Beats Q1 Earnings Estimates
by Zacks Equity Research
American International Group (AIG) delivered earnings and revenue surprises of 11.43% and 2.59%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Oscar Health, Inc. (OSCR) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $13.01, denoting a -1.06% change from the preceding trading day.
Oscar Health, Inc. (OSCR) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $11.60, representing a -0.34% change from its previous close.
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
Oscar Health, Inc. (OSCR) closed at $12.42 in the latest trading session, marking a -1.19% move from the prior day.
Oscar Health, Inc. (OSCR) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $13.61, indicating a +1.8% shift from the previous trading day.
Oscar Health, Inc. (OSCR) Stock Moves -1.34%: What You Should Know
by Zacks Equity Research
Oscar Health, Inc. (OSCR) closed the most recent trading day at $13.30, moving -1.34% from the previous trading session.